RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus.
Cernaro V, Loddo S, Macaione V, Ferlazzo VT, Cigala RM, Crea F, De Stefano C, Genovese ARR, Gembillo G, Bolignano D, Santoro D, Vita R, Buemi M, Benvenga S.
Cernaro V, et al. Among authors: gembillo g.
Int Urol Nephrol. 2020 Jun;52(6):1125-1133. doi: 10.1007/s11255-020-02469-z. Epub 2020 Apr 20.
Int Urol Nephrol. 2020.
PMID: 32314169